MIBio 2025

We are delighted to announce the 13th MIBio conference, which will take place at the Howard Theatre, Downing College, Cambridge, on 15 October 2025.

MIBio 2025 will bring together leading experts from both industry and academia to explore how the latest discoveries in molecular interactions can be leveraged in biopharmaceutical formulation. Our discussions will focus on creating therapeutic products that are more effective, patient-friendly, and safe.

As the number of biological therapies expands, there is a growing need for prefilled devices that can be used by patients or caregivers, despite the challenges posed by the requirement of high therapeutic doses. Additionally, the development of longer-acting injectable compositions and therapeutic formulas for various delivery routes continually advances. These innovations call for intelligent drug product design and seamless drug-device integration throughout the development process to ensure optimal performance for patient benefit.

This year's conference will delve into the current state-of-the-art and potential future developments in these pivotal areas. We anticipate welcoming approximately 100 delegates from the biopharma industry, academia, and technology suppliers, creating a stimulating environment for new collaborations and breakthroughs in drug product development.

We invite abstract submissions for poster presentations and welcome applications for sponsorship and exhibitor opportunities. Join us at MIBio 2025 to engage in inspiring discussions and shape the future of biopharmaceutical innovation.

We look forward to seeing you there!

MIBio Organising Committee

Jan Jezek | Arecor

Nicholas J Darton | AstraZeneca

Tejash Shah | GSK

Stephen Harding | University of Nottingham

Bernardo Perez-Ramirez | Sanofi

Bin Yang | AstraZeneca

Priyanka Dey | Portsmouth University

Thank you to the support of The Royal Society of Chemistry